Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease

Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease

Meningococcal disease, including meningitis and sepsis, usually follows an invasive infection by Neisseria meningitidis, and is a major cause of death and morbidity worldwide. Currently available meningococcal vaccines that consist of pure capsular polysaccharides (serogroups A, C, W-135 and Y) are...

Full description

Bibliographic Details
Main Authors: Pei-Lan Shao, Luan-Yin Chang, Szu-Min Hsieh, Shan-Chwen Chang, Sung-Ching Pan, Chun-Yi Lu, Yu-Chia Hsieh, Chin-Yun Lee, Kurt Dobbelaere, Dominique Boutriau, Haiwen Tang, Hans L. Bock, Li-Min Huang
Format: Article
Language:English
Published: Elsevier 2009-07-01
Series:Journal of the Formosan Medical Association
Subjects:
immune response
meningococcal vaccines
Neisseria meningitidis
Taiwan
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664609603715

Internet

http://www.sciencedirect.com/science/article/pii/S0929664609603715

Similar Items